Evidence map›Paper›PMID 35971445›Full record

ArticleInternational journal of nanomedicine2022

A SERS Platform for Rapid Detection of Drug Resistance of Non-

Feng Gu, Shan Hu, Yunjian Wu, Changyu Wu, Ying Yang, Bing Gu, Hong Du

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of nanomedicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Rapid antifungal phenotypic detection ofFrontiers in cellular and infection microbiology · 2026
    Article
  3. Characterization, Molecular Mechanism of Prochloraz-Resistance inJournal of fungi (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Feng Gu *Department of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China.
Shan Hu *Department of Laboratory Medicine, Xuzhou Tumor Hospital, Xuzhou, 221005, People's Republic of China.
Yunjian Wu *School of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Changyu WuSchool of Medical Imaging, Xuzhou Medical University, Xuzhou, 221004, People's Republic of China.
Ying YangDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing Key Laboratory of New Molecular Diagnosis Technologies for Infectious Diseases, Beijing, 100850, People's Republic of China.
Bing GuGuangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, 510000, People's Republic of China.
Hong DuDepartment of Clinical Laboratory, The Second Affiliated Hospital of Soochow University, Suzhou, 215004, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Materials and Methods: Fe Results: SERS combined with OPLS-DA could well analyze the drug resistance of non- Conclusion: This approach can be utilized without causing damage to the cell wall and can be accomplished in as little as 90 minutes. It can provide timely guidance for the treatment of patients with good clinical application potential.

Indexed as

CandidiasisMetal NanoparticlesDrug ResistanceHumansLeast-Squares AnalysisSilverSpectrum Analysis, RamanSilverdrug resistancenon-Candida albicansOPLS-DASERS

Identifiers

PMID35971445
PMCPMC9375581

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.